# SCLife®-LDD hUC-MSCs Injection Therapy for Patients With Lumbar Intervertebral Disc Degeneration

> **NCT06589271** · PHASE1 · SUSPENDED · sponsor: **Sclnow Biotechnology Co., Ltd.** · enrollment: 20 (estimated)

## Conditions studied

- Lumbar Disc Degeneration

## Interventions

- **BIOLOGICAL:** human umbilical cord mesenchymal stem cell suspension
- **PROCEDURE:** total endoscopic extraction of lumbar nucleus pulposus

## Key facts

- **NCT ID:** NCT06589271
- **Lead sponsor:** Sclnow Biotechnology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2026-12-31
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Why stopped:** Lack of financial support
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06589271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06589271, "SCLife®-LDD hUC-MSCs Injection Therapy for Patients With Lumbar Intervertebral Disc Degeneration". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06589271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*